Juan Richtmon

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
This study evaluates the prognostic value of minimal residual disease (MRD) monitoring by multiparametric flow cytometry in 41 patients with acute myeloid leukemia or myelodysplastic syndrome(More)
  • 1